Trump drug costs order anticipated to incorporate hyperlink to prices abroad
WASHINGTON — President Trump is broadly anticipated to attempt to advance a “most-favored nation” coverage subsequent week in an effort to scale back U.S. drug costs — a transfer that’s more likely to considerably rattle the pharmaceutical trade, cheer his political base, and, probably, depart open some very large questions.
The thought behind the coverage, typically talking, is straightforward: It might tie funds for medicine in the USA to costs paid by different high-income international locations, lots of which pay far lower than People for his or her drugs. It’s additionally not a brand new thought: The primary Trump administration tried to set it in movement, just for its plans to be blocked.
However now, having realized the teachings from that defeat, and with a majority within the Home and the Senate, the administration might face higher odds.
This text is unique to STAT+ subscribers
Unlock this text — plus day by day intelligence on Capitol Hill and the life sciences trade — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
